The COVID-19 Pandemic and Coronary Angiography for ST-Elevation Myocardial Infarction, Use of Mechanical Support, and Mechanical Complications in Canada: A Canadian Association of Interventional Cardiology National Survey

Autor: Stéphane Rinfret, MD, SM, Israth Jahan, BSc, Kevin McKenzie, Nandini Dendukuri, PhD, Kevin R. Bainey, MD, MSc, Samer Mansour, MD, Madhu Natarajan, MD, Luiz F. Ybarra, MD, PhD, MBA, Aun-Yeong Chong, BSc, MBBS, MD, MRCP, Simon Bérubé, MD, Robert Breton, MD, Michael J. Curtis, MD, Josep Rodés-Cabau, MD, Amlani Shy (Shoaib), MD, Alireza Bagherli, MD, Warren Ball, MD, Alan Barolet, MD, PhD, Hussein K. Beydoun, MD, Neil Brass, MD, Albert W. Chan, MD, MSc, Franco Colizza, MD, Christian Constance, MD, Neil P. Fam, MD, MSc, François Gobeil, MD, Tinouch Haghighat, MD, Steven Hodge, MD, Dominique Joyal, MD, Hahn Hoe Kim, MD, CM, Sohrab Lutchmedial, MD, Andrea MacDougall, MD, Paul Malik, MD, Steve Miner, MD, Kunal Minhas, BSc, MD, Jason Orvold, MD, Donald Palisaitis, MD, Brendan Parfrey, MD, Jean-Michel Potvin, MD, Geoffrey Puley, MD, Sam Radhakrishnan, MD, Marco Spaziano, MD, Jean-François Tanguay, MD, Ram Vijayaraghaban, MD, John G. Webb, MD, Rodney H. Zimmermann, MD, David A. Wood, James M. Brophy, MD, PhD

Publikováno v: CJC Open, Vol 3, Iss 9, Pp 1125-1131 (2021)

Background: As a result of the COVID-19 pandemic first wave, reductions in ST-elevation myocardial infarction (STEMI) invasive care, ranging from 23% to 76%, have been reported from various countries. Whether this change had any impact on coronary an

Externí odkaz: https://doaj.org/article/a8bf8c71b9a14374baffa5709e52ace1

Canadian Spontaneous Coronary Artery Dissection Cohort Study

Autor: Jacqueline Saw, Andrew Starovoytov, Eve Aymong, Taku Inohara, Mesfer Alfadhel, Cameron McAlister, Rohit Samuel, Tejana Grewal, Johandra Argote Parolis, Tej Sheth, Derek So, Kunal Minhas, Neil Brass, Andrea Lavoie, Helen Bishop, Shahar Lavi, Colin Pearce, Suzanne Renner, Mina Madan, Robert C. Welsh, Brent M. McGrath, Ram Vijayaraghavan, Bryan Har, Reda Ibrahim, Pulkit Chaudhary, Santhi K. Ganesh, John Graham, Alexis Matteau, Giuseppe Martucci, Dennis T. Ko, Karin Humphries, GB John Mancini

Publikováno v: Journal of the American College of Cardiology. 80:1585-1597

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::29ee5cde7d854110f31c39830d65e2c2
https://doi.org/10.1016/j.jacc.2022.08.759

Use and outcomes of dual antiplatelet therapy for acute coronary syndrome in patients with chronic kidney disease: insights from the Canadian Observational Antiplatelet Study (COAPT)

Autor: Carol Anne Graham, Mary K. Tan, Derek P. Chew, Christopher P. Gale, Keith A. A. Fox, Akshay Bagai, Mark A. Henderson, Ata ur Rehman Quraishi, Jean-Pierre Déry, Asim N. Cheema, Harold Fisher, David Brieger, Sohrab R. Lutchmedial, Shahar Lavi, Brian Y. L. Wong, Tomas Cieza, Shamir R. Mehta, Neil Brass, Shaun G. Goodman, Andrew T. Yan

Publikováno v: Heart and Vessels. 37:1291-1298

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::72ad544e11eb651b12ec6d9867c5490a
https://doi.org/10.1007/s00380-022-02029-8

Rationale and Design for the Myocardial Ischemia and Transfusion (MINT) Randomized Clinical Trial

Autor: Jeffrey L. Carson, Maria Mori Brooks, Bernard R. Chaitman, John H. Alexander, Shaun G. Goodman, Marnie Bertolet, J. Dawn Abbott, Howard A. Cooper, Sunil V. Rao, Darrell J. Triulzi, Dean A. Fergusson, William J. Kostis, Helaine Noveck, Tabassome Simon, Philippe Gabriel Steg, Andrew P. DeFilippis, Andrew M. Goldsweig, Renato D. Lopes, Harvey White, Caroline Alsweiler, Erin Morton, Paul C. Hébert, Shahab Ghafghazi, Frances Wood, Mark Menegus, Barry Uretsky, Srikanth Vallurupalli, Gregory Maniatis, Luis Gruberg, Robert Roswell, Joseph Rossi, Farhad Abtahian, Meechai Tessalee, Gregory Barsness, Herbert Aronow, Kodangudi Ramanathan, Mark Schmidhofer, Friederike Keating, Michael Carson, Michael Kontos, Mansoor Qureshi, Stacey Clegg, Warren Laskey, Tamar Polonsky, Rajesh Gupta, Mujeeb Abdul Sheikh, Lynne Uhl, Paul Mullen, Arthur Bracey, William Matthai, Christopher Stowell, David Dudzinski, Gregary Marhefka, Perry Weinstock, William Lawson, Norma Keller, Eugene Yuriditsky, Michael Thomas, Alice Jacobs, Claudia Hochberg, Omar Siddiqi, Joshua Schulman-Marcus, Mikhail Torosoff, Michael Gitter, Xuming Dai, Jay Traverse, Eric McCamant, Jason Scott, Rajesh Swaminathan, Sunil Rao, Adam Salisbury, David Landers, Ganesh Raveendran, Ramin Ebrahimi, Richard Bach, Joseph Delehanty, Raj C. Shah, Sorin Brener, Jonathan Doroshow, Adriano Caixeta, Dalton Precoma, Frederico Toledo Campo Dall'Orto, Pedro Beraldo De Andrade, Marianna Dracoulakis, Lília Nigro Maia, Luiz Eduardo Fontelles Ritt, Alexandre Quadros, Dário Celestino Sobral Filho, Fernando De Martino, Thao Huynh, Greg Schnell, Manohara Senaratne, Vikas Tandon, John Neary, David Laflamme, Jean-Pierre Dery, Kevin Bainey, Richard Haichin, Payam Dehghani, Ata Ur Rehman Quraishi, Brian J. Potter, François Martin Carrier, Michael Goldfarb, Christopher Fordyce, Ying Tung Sia, Benoit Daneault, Mina Madan, Terry McPherson, John Ducas, Kunal Minhas, Neil Brass, Akshay Bagai, Simon Robinson, Vladimír Džavík, Razi Khan, Nicolas Michaud, Gabriel Steg, Gregory Ducrocq, Etienne Puymirat, Gilles Lemesle, Emile Ferrari, Benoit Lattuca, Johanne Silvain, Gérald Vanzetto, Laura Cetran, Thibault Lhermusier, Yves Cottin, Yann Rosamel, Denis Angoulvant, Jean Guillaume Dillinger, Christophe Thuaire, Batric Popovic, Eric Durand, Claire Bouleti, François Roubille, Laurent Delorme, Ian Crozier, Jocelyne Benatar, Samraj Nandra, Ian Ternouth, Nick Fisher, David Brieger, Graham Hillis

Publikováno v: American heart journal.

Accumulating evidence from clinical trials suggests that a lower (restrictive) hemoglobin threshold (8% g/dL) for red blood cell (RBC) transfusion, compared with a higher (liberal) threshold (≥10 g/dL) is safe. However, in anemic patients with acut

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8f8dc44f98a98cf5b59495acd8d5eb6
https://pubmed.ncbi.nlm.nih.gov/36417955

Use and outcomes of dual antiplatelet therapy for acute coronary syndrome in patients with chronic kidney disease: insights from the Canadian Observational Antiplatelet Study (COAPT)

Autor: Carol Anne, Graham, Mary K, Tan, Derek P, Chew, Christopher P, Gale, Keith A A, Fox, Akshay, Bagai, Mark A, Henderson, Ata Ur Rehman, Quraishi, Jean-Pierre, Déry, Asim N, Cheema, Harold, Fisher, David, Brieger, Sohrab R, Lutchmedial, Shahar, Lavi, Brian Y L, Wong, Tomas, Cieza, Shamir R, Mehta, Neil, Brass, Shaun G, Goodman, Andrew T, Yan

Publikováno v: Heart and vessels. 37(8)

Chronic kidney disease (CKD) increases the risk of adverse outcomes in acute coronary syndrome (ACS). The optimal regimen of dual antiplatelet therapy (DAPT) post-percutaneous coronary intervention (PCI) in CKD poses a challenge due to the increased

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bd2e0e73e4f3f4767fda21a488823d02
https://pubmed.ncbi.nlm.nih.gov/35089380